MicroRNAs and head and neck cancer: reviewing the first decade of research.

[1]  C. Croce,et al.  Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway , 2014, Oncogene.

[2]  T. Yen,et al.  miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis. , 2014, Cancer research.

[3]  E. Pinatel,et al.  miR-223 Is a Coordinator of Breast Cancer Progression as Revealed by Bioinformatics Predictions , 2014, PloS one.

[4]  E. Domany,et al.  Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  G. Fisher,et al.  Role of Met Axis in Head and Neck Cancer , 2013, Cancers.

[6]  Dong Chen,et al.  Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell. , 2013, International journal of clinical and experimental pathology.

[7]  Sun-Young Park,et al.  MicroRNA-205 suppresses the oral carcinoma oncogenic activity via down-regulation of Axin-2 in KB human oral cancer cell , 2013, Molecular and Cellular Biochemistry.

[8]  Y. Okamoto,et al.  Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin–integrin signalling in head and neck squamous cell carcinoma , 2013, British Journal of Cancer.

[9]  Shu-Chun Lin,et al.  miR-211 promotes the progression of head and neck carcinomas by targeting TGFβRII. , 2013, Cancer letters.

[10]  E. Ratovitski,et al.  Phospho‐ΔNp63α‐dependent microRNAs modulate chemoresistance of squamous cell carcinoma cells to cisplatin: At the crossroads of cell life and death , 2013, FEBS letters.

[11]  C. R. Leemans,et al.  Identification of Lethal microRNAs Specific for Head and Neck Cancer , 2013, Clinical Cancer Research.

[12]  L. Tamer,et al.  Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma , 2013, Journal of Cancer Research and Clinical Oncology.

[13]  S. Jeng,et al.  MicroRNA-17-5p post-transcriptionally regulates p21 expression in irradiated betel quid chewing-related oral squamous cell carcinoma cells , 2013, Strahlentherapie und Onkologie.

[14]  Xinwei Chen,et al.  Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line. , 2013, International journal of clinical and experimental pathology.

[15]  W. Reinhold,et al.  Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA–mRNA interactions , 2013, Molecular biology of the cell.

[16]  Duan Ma,et al.  Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma , 2013, Head & neck.

[17]  K. Saito,et al.  MicroRNA-125b regulates proliferation and radioresistance of oral squamous cell carcinoma , 2013, British Journal of Cancer.

[18]  Y. Okamoto,et al.  Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma , 2013, British Journal of Cancer.

[19]  C. Murdoch,et al.  Cigarette smoke condensate promotes pro-tumourigenic stromal-epithelial interactions by suppressing miR-145. , 2013, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[20]  J. Kjems,et al.  MicroRNA-137 promoter methylation in oral lichen planus and oral squamous cell carcinoma. , 2013, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[21]  K. Juhász,et al.  miRNA expression profiles of oral squamous cell carcinomas. , 2013, Anticancer research.

[22]  Hongliang Liu,et al.  A functional variant at the miR‐885‐5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  Wen-Hao Yang,et al.  Repression of bone morphogenetic protein 4 by let-7i attenuates mesenchymal migration of head and neck cancer cells. , 2013, Biochemical and biophysical research communications.

[24]  Xi Yang,et al.  Progress risk assessment of oral premalignant lesions with saliva miRNA analysis , 2013, BMC Cancer.

[25]  Zong-fang Li,et al.  Downregulation of miR-145 Expression in Oral Squamous Cell Carcinomas and Its Clinical Significance , 2013, Oncology Research and Treatment.

[26]  K. Gopinath,et al.  Primary Microcephaly Gene MCPH1 Shows Signatures of Tumor Suppressors and Is Regulated by miR-27a in Oral Squamous Cell Carcinoma , 2013, PloS one.

[27]  L. Waldron,et al.  Potentially Prognostic miRNAs in HPV-Associated Oropharyngeal Carcinoma , 2013, Clinical Cancer Research.

[28]  Xueru Mu,et al.  MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met. , 2013, International journal of oncology.

[29]  Qin Xu,et al.  Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin. , 2013, The international journal of biochemistry & cell biology.

[30]  J. Inazawa,et al.  Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer. , 2013, Carcinogenesis.

[31]  F. Yu,et al.  The Overexpression of Hypomethylated miR-663 Induces Chemotherapy Resistance in Human Breast Cancer Cells by Targeting Heparin Sulfate Proteoglycan 2 (HSPG2)* , 2013, The Journal of Biological Chemistry.

[32]  Wei Zhang,et al.  Overexpression of miR -155 Promotes Proliferation and Invasion of Human Laryngeal Squamous Cell Carcinoma via Targeting SOCS1 and STAT3 , 2013, PloS one.

[33]  Q. Wei,et al.  MicroRNA Variants Increase the Risk of HPV-Associated Squamous Cell Carcinoma of the Oropharynx in Never Smokers , 2013, PloS one.

[34]  X. Wan,et al.  miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer , 2013, Medical Oncology.

[35]  A. Levine,et al.  miR-143 regulates hexokinase 2 expression in cancer cells , 2013, Oncogene.

[36]  Pei Wang,et al.  The Association between Genetic Polymorphism and the Processing Efficiency of miR-149 Affects the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma , 2012, PloS one.

[37]  A. Lund,et al.  MicroRNA and cancer , 2012, Molecular oncology.

[38]  K. Gopinath,et al.  Oncogenic MicroRNA-155 Down-regulates Tumor Suppressor CDC73 and Promotes Oral Squamous Cell Carcinoma Cell Proliferation , 2012, The Journal of Biological Chemistry.

[39]  P. Leedman,et al.  Regulation of Epidermal Growth Factor Receptor Signaling and Erlotinib Sensitivity in Head and Neck Cancer Cells by miR-7 , 2012, PloS one.

[40]  Xin Li,et al.  miR-1297 mediates PTEN expression and contributes to cell progression in LSCC. , 2012, Biochemical and biophysical research communications.

[41]  Kai Fu,et al.  Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas. , 2012, Cancer cell.

[42]  Hongbing Shen,et al.  Genetic Variations in Key MicroRNA Processing Genes and Risk of Head and Neck Cancer: A Case-Control Study in Chinese Population , 2012, PloS one.

[43]  B. Yan,et al.  Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells. , 2012, Molecular medicine reports.

[44]  Dongsheng Yu,et al.  Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. , 2012, Oral oncology.

[45]  U. Bhawal,et al.  Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer , 2012, British Journal of Cancer.

[46]  Ming-Yu Yang,et al.  Circulating miRNA is a novel marker for head and neck squamous cell carcinoma , 2012, Tumor Biology.

[47]  C. Garnis,et al.  Differential expression of miRNAs in the serum of patients with high-risk oral lesions , 2012, Cancer medicine.

[48]  W. Kong,et al.  Keratinization-associated miR-7 and miR-21 Regulate Tumor Suppressor Reversion-inducing Cysteine-rich Protein with Kazal Motifs (RECK) in Oral Cancer* , 2012, The Journal of Biological Chemistry.

[49]  Mu-Kuan Chen,et al.  Impacts of MicroRNA Gene Polymorphisms on the Susceptibility of Environmental Factors Leading to Carcinogenesis in Oral Cancer , 2012, PloS one.

[50]  Zengtong Zhou,et al.  Upregulation of miR-31* Is Negatively Associated with Recurrent/Newly Formed Oral Leukoplakia , 2012, PloS one.

[51]  A. Kallioniemi,et al.  Both inhibition and enhanced expression of miR‐31 lead to reduced migration and invasion of pancreatic cancer cells , 2012, Genes, chromosomes & cancer.

[52]  Y. Okamoto,et al.  Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma. , 2012, International journal of oncology.

[53]  J. Datta,et al.  Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[54]  A. Yadav,et al.  Dysregulation of MicroRNA-34a Expression in Head and Neck Squamous Cell Carcinoma Promotes Tumor Growth and Tumor Angiogenesis , 2012, PloS one.

[55]  Mark E. Davis,et al.  Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[56]  Kylie L. Gorringe,et al.  MicroRNA Genes and Their Target 3′-Untranslated Regions Are Infrequently Somatically Mutated in Ovarian Cancers , 2012, PloS one.

[57]  F. Nielsen,et al.  The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer , 2012, British Journal of Cancer.

[58]  George A Calin,et al.  Functional relevance of miRNA sequences in human disease. , 2012, Mutation research.

[59]  Thomas M. Harris,et al.  Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. , 2012, The American journal of pathology.

[60]  Shu-Chun Lin,et al.  Exploiting salivary miR‐31 as a clinical biomarker of oral squamous cell carcinoma , 2012, Head & neck.

[61]  Ming Sun,et al.  MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4 , 2012, Journal of Cancer Research and Clinical Oncology.

[62]  Yao Sun,et al.  miR-21 inhibitor sensitizes human OSCC cells to cisplatin , 2012, Molecular Biology Reports.

[63]  S. Clark,et al.  Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer , 2012, Oncogene.

[64]  G. Calin,et al.  MicroRNA history: discovery, recent applications, and next frontiers. , 2011, Mutation research.

[65]  M. Zhong,et al.  miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein , 2011, Oncology reports.

[66]  Susan J. Clark,et al.  MicroRNA Alterations and Associated Aberrant DNA Methylation Patterns across Multiple Sample Types in Oral Squamous Cell Carcinoma , 2011, PloS one.

[67]  P. Pandolfi,et al.  Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. , 2011, Cancer cell.

[68]  Yi Jin,et al.  MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines. , 2011, The Biochemical journal.

[69]  Ming Liu,et al.  Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. , 2011, Anticancer research.

[70]  A. Hui,et al.  Significance of Dysregulated Metadherin and MicroRNA-375 in Head and Neck Cancer , 2011, Clinical Cancer Research.

[71]  Jhi-Joung Wang,et al.  Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer. , 2011, Oncology reports.

[72]  Chien-Hung Lee,et al.  Areca nut induces miR-23a and inhibits repair of DNA double-strand breaks by targeting FANCG. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[73]  R. Gibbs,et al.  Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 , 2011, Science.

[74]  Y. Okamoto,et al.  Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC) , 2011, Journal of Human Genetics.

[75]  Gabriel Wong,et al.  Stem Cell Marker (Nanog) and Stat-3 Signaling Promote MicroRNA-21 Expression and Chemoresistance in Hyaluronan/CD44-activated Head and Neck Squamous Cell Carcinoma Cells , 2011, Oncogene.

[76]  S. Varambally,et al.  The tumor suppressor gene rap1GAP is silenced by mir-101-mediated EZH2 overexpression in invasive squamous cell carcinoma , 2011, Oncogene.

[77]  Elizabeth E. Hoskins,et al.  Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus , 2011, Head & neck.

[78]  R. Stone,et al.  MicroRNA‐137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck , 2011, Cancer.

[79]  R. Weinberg,et al.  Activation of miR-31 function in already-established metastases elicits metastatic regression. , 2011, Genes & development.

[80]  Guang-Yuh Chiou,et al.  MicroRNA‐200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells , 2011, The Journal of pathology.

[81]  Guang-Yuh Chiou,et al.  MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. , 2011, Oral oncology.

[82]  Vidar Skaug,et al.  The Association of MicroRNA Expression with Prognosis and Progression in Early-Stage, Non–Small Cell Lung Adenocarcinoma: A Retrospective Analysis of Three Cohorts , 2011, Clinical Cancer Research.

[83]  Ankit Malhotra,et al.  miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. , 2011, Cancer research.

[84]  C. von Buchwald,et al.  Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study , 2011, British Journal of Cancer.

[85]  Min Liu,et al.  MicroRNA‐16 targets zyxin and promotes cell motility in human laryngeal carcinoma cell line HEp‐2 , 2011, IUBMB life.

[86]  N. Park,et al.  miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras. , 2011, Biochemical and biophysical research communications.

[87]  Yoshitaka Okamoto,et al.  miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma , 2011, Oncotarget.

[88]  Adam V Jones,et al.  MicroRNA‐124 suppresses oral squamous cell carcinoma motility by targeting ITGB1 , 2011, FEBS letters.

[89]  Ming Liu,et al.  Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma. , 2010, European journal of cancer.

[90]  Edward S. Kim,et al.  MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer. , 2010, Carcinogenesis.

[91]  Feng-jun Wang,et al.  Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. , 2010, Gynecologic oncology.

[92]  B. Sjöström,et al.  miRNA analysis of formalin-fixed squamous cell carcinomas of the tongue is affected by age of the samples. , 2010, International journal of oncology.

[93]  A. Kolokythas,et al.  MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. , 2010, The Biochemical journal.

[94]  A. Palmieri,et al.  MicroRNA Expression Profiling of Oral Carcinoma Identifies New Markers of Tumor Progression , 2010, International journal of immunopathology and pharmacology.

[95]  A. Kolokythas,et al.  MicroRNA‐24 targeting RNA‐binding protein DND1 in tongue squamous cell carcinoma , 2010, FEBS letters.

[96]  R. Gilbert,et al.  Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma , 2010, Molecular Cancer.

[97]  F. Slack,et al.  OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma , 2010, Nature.

[98]  Y. Okamoto,et al.  miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC) , 2010, British Journal of Cancer.

[99]  S. Peng,et al.  Association of MicroRNA-196a-2 Gene Polymorphism with Gastric Cancer Risk in a Chinese Population , 2010, Digestive Diseases and Sciences.

[100]  Guanghai Yang,et al.  MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). , 2010, Clinica chimica acta; international journal of clinical chemistry.

[101]  Richard J Lamont,et al.  Overexpression of dicer as a result of reduced let‐7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells , 2010, Genes, chromosomes & cancer.

[102]  J. Lovén,et al.  Targeting MYC-Regulated miRNAs to Combat Cancer. , 2010, Genes & cancer.

[103]  Rondi A. Butler,et al.  Mature MicroRNA Sequence Polymorphism in MIR196A2 Is Associated with Risk and Prognosis of Head and Neck Cancer , 2010, Clinical Cancer Research.

[104]  M. Siomi,et al.  Posttranscriptional regulation of microRNA biogenesis in animals. , 2010, Molecular cell.

[105]  S. Kao,et al.  Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. , 2010, Oral diseases.

[106]  M. Salto‐Tellez,et al.  MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. , 2010, European journal of cancer.

[107]  J. Ragoussis,et al.  hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer , 2010, Cancer.

[108]  Ping Zhang,et al.  MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines. , 2010, Oral oncology.

[109]  M. Seto,et al.  MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. , 2010, Cancer research.

[110]  P. Gunaratne,et al.  Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. , 2010, Cancer research.

[111]  S. Chiou,et al.  miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. , 2010, Cancer research.

[112]  Wei Shi,et al.  Comprehensive MicroRNA Profiling for Head and Neck Squamous Cell Carcinomas , 2010, Clinical Cancer Research.

[113]  S. Lippman,et al.  Genetic variation in MicroRNA genes and risk of oral premalignant lesions , 2010, Molecular carcinogenesis.

[114]  Lu Jiang,et al.  MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. , 2009, Cancer letters.

[115]  Igor Jurisica,et al.  Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. , 2009, Human molecular genetics.

[116]  C. Marsit,et al.  MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. , 2009, Carcinogenesis.

[117]  N. Park,et al.  Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection , 2009, Clinical Cancer Research.

[118]  G. Kristiansen,et al.  Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma , 2009, International journal of cancer.

[119]  Deepak Srivastava,et al.  miR-145 and miR-143 Regulate Smooth Muscle Cell Fate Decisions , 2009, Nature.

[120]  E. Feingold,et al.  Decreased expression of miR‐125b and miR‐100 in oral cancer cells contributes to malignancy , 2009, Genes, chromosomes & cancer.

[121]  Yandan Yao,et al.  MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor , 2009, Clinical Cancer Research.

[122]  I. Faraoni,et al.  miR-155 gene: a typical multifunctional microRNA. , 2009, Biochimica et biophysica acta.

[123]  Brock C Christensen,et al.  A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers. , 2009, Carcinogenesis.

[124]  K. Coombes,et al.  miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue , 2009, Head & neck.

[125]  B. Christensen,et al.  MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma , 2009, Clinical Cancer Research.

[126]  Hongbing Shen,et al.  A Functional Genetic Variant in microRNA-196a2 Is Associated with Increased Susceptibility of Lung Cancer in Chinese , 2009, Cancer Epidemiology Biomarkers & Prevention.

[127]  K. Mimori,et al.  Over- and under-expressed microRNAs in human colorectal cancer. , 2009, International journal of oncology.

[128]  K. Zatloukal,et al.  miR‐29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis , 2009, EMBO reports.

[129]  Geoffrey Childs,et al.  Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. , 2009, The American journal of pathology.

[130]  John S Mattick,et al.  Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7* , 2009, Journal of Biological Chemistry.

[131]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[132]  C. Sander,et al.  DGCR8-dependent microRNA biogenesis is essential for skin development , 2009, Proceedings of the National Academy of Sciences.

[133]  Jan-Fang Cheng,et al.  Dicer, Drosha, and outcomes in patients with ovarian cancer. , 2008, The New England journal of medicine.

[134]  David Sidransky,et al.  MicroRNA alterations in head and neck squamous cell carcinoma , 2008, International journal of cancer.

[135]  Qiong Shao,et al.  MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. , 2008, RNA.

[136]  V. Ambros,et al.  The evolution of our thinking about microRNAs , 2008, Nature Medicine.

[137]  Alice Shapiro,et al.  MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. , 2008, Cancer research.

[138]  Zhenbao Yu,et al.  Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. , 2008, Carcinogenesis.

[139]  Wendy Frankel,et al.  MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival , 2008, Journal of Gastrointestinal Surgery.

[140]  Nathalie Wong,et al.  MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. , 2008, Gastroenterology.

[141]  Yunqing Li,et al.  microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. , 2008, Cancer research.

[142]  William Ignace Wei,et al.  Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue , 2008, Clinical Cancer Research.

[143]  J. Inazawa,et al.  Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. , 2008, Cancer research.

[144]  Elaine Fuchs,et al.  A skin microRNA promotes differentiation by repressing ‘stemness’ , 2008, Nature.

[145]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[146]  L. Lim,et al.  MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression , 2008, Molecular and Cellular Biology.

[147]  A. Krogh,et al.  Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells* , 2008, Journal of Biological Chemistry.

[148]  T. Patel,et al.  Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes , 2008, Oncogene.

[149]  C. Morrison,et al.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.

[150]  C. Benz,et al.  Coordinate Suppression of ERBB2 and ERBB3 by Enforced Expression of Micro-RNA miR-125a or miR-125b* , 2007, Journal of Biological Chemistry.

[151]  Rajiv Dhir,et al.  Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. , 2006, The American journal of pathology.

[152]  X. Agirre,et al.  Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues , 2006, Molecular Cancer.

[153]  Vladimir Benes,et al.  A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). , 2006, RNA.

[154]  S. Salzberg,et al.  The Transcriptional Landscape of the Mammalian Genome , 2005, Science.

[155]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[156]  Shuta Tomida,et al.  Reduced expression of Dicer associated with poor prognosis in lung cancer patients , 2005, Cancer science.

[157]  A. Leclerc,et al.  Smoking, alcohol drinking, occupational exposures and social inequalities in hypopharyngeal and laryngeal cancer. , 2004, International journal of epidemiology.

[158]  R. Brentani,et al.  Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas. , 2004, Cancer detection and prevention.

[159]  A. Leclerc,et al.  Smoking, alcohol drinking and cancer risk for various sites of the larynx and hypopharynx. A case–control study in France , 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[160]  Iver Petersen,et al.  Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis , 2003, The Journal of pathology.

[161]  Tim Crook,et al.  The p53 network in head and neck cancer. , 2003, Oral oncology.

[162]  Timothy B. Stockwell,et al.  The Sequence of the Human Genome , 2001, Science.

[163]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[164]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[165]  B. Reinhart,et al.  Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA , 2000, Nature.

[166]  Xiaowei Wang,et al.  A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma , 2013, Cancer.

[167]  D. Crowe,et al.  Role of microRNA-138 as a potential tumor suppressor in head and neck squamous cell carcinoma. , 2013, International review of cell and molecular biology.

[168]  I. Ember,et al.  Association of pre-miR-146a rs2910164 polymorphism with the risk of head and neck cancer. , 2013, Anticancer research.

[169]  Fang Zhang,et al.  Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas. , 2012, Oral oncology.

[170]  Fang Zhou,et al.  Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. , 2008, Cancer research.

[171]  Joseph A Califano,et al.  Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. , 2006, The Lancet. Oncology.

[172]  A. Olshan,et al.  Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. , 2004, American journal of epidemiology.